2015 - TID 2015 Conference


Transplant in the Tropics

3.4 - Endemic Mycoses Cocci, Paracocci, Histo

Presenter: Ligia C., Pierrotti, , Brazil
Authors: Ligia C. Pierrotti


Overview

Endemic tropical mycoses include paracoccidiodomycosis in Latin America, and coccidiodomycosis and histoplasmosis in the Americas. The large majority of patients exposed to these funguses remains asymptomatic or develop only mild symptoms. Medical conditions that impaired T cell immunity, including solid organ transplants (SOT), however, is a recognized risk for disease development and dissemination.

Since endemic mycoses are not reportable diseases in most countries, the epidemiological and clinical data are fragmentary and limited, based on case reports and single-center studies.

Endemic mycoses in SOT can occur via primary infection, reactivation of previous latent infections, re-infection in patients with prior exposure, or due donor-derived infection.

Although endemic mycoses occur infrequently, active disease may case serious and life-threating infections in patients with SOT, and clinical suspicion is essential for early diagnosis and therapy. 

Objectives

After this lecture, you will be able to discuss about:

  • Epidemiology of Endemic Mycosis - Cocci, Paracocci, Histo
  • Risk assessment of endemic mycoses in the tropics – who should be screened or monitor.
  • Clinical presentation
  • Diagnosis challenges
  • Treatment and prophylaxis 

You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi